BotHead™ Blog

Brown University through a grant by the Department of Defense (DOD) has developed a novel automated tissue manufacturing process using BAB.

This blog post discusses a study conducted by Advanced Solutions using a 3D in vitro model

Tissue organoids, also known as "mini organs," possess vast potential as tools for various applications, such as disease modeling, drug screening, and tissue engineering. To effectively imitate the native tissue environment, it is essential to integrate a microvasculature with the parenchyma and stroma.

Turnkey platform integrates flexible robotic automation with high-content imaging of complex 3D cellular models.

Organoids and spheroids are proving to be useful tools in drug target discovery and screening.

To begin exploring the utility of the model for NAFLD/NASH, liver tissues were exposed to a high fat medium (HFM) comprised of a base medium supplemented with glucose (25mM), palmitic acid (45μM), and sodium oleate (65μM).

October is Breast Cancer Awareness Month and BAB is empowering women with a new type of breast prosthetics through pioneering research.

BioAssemblyBot® Featured at ‘Life Itself’

BioAssemblyBot Meets Dr. Doris Taylor

BioAssemblyBot®, or BAB, as we call her, will be featured at Life Itself event in San Diego.

The BioAssemblyBot®500 has been named a finalist for Product of the Year by the New Hampshire Tech Alliance.

Biomaterials used for fabricating 3D tissue constructs need to provide a permissive environment for cellular processes.

lding on the bioassembly revolution, Advanced Solutions announces the latest bioprinter in the BioAssemblyBot® technology platform.

The BioAssemblyBot® technology platform can automatically switch between different tools or print heads as required for different tasks.

Advanced Solutions announced partnerships with the leading medical and research technology solution providers in Qatar and the UAE.

3D bioprinting vasculatures is perhaps the holy grail of the next industrial revolution in healthcare.

Review the different considerations required for developing facilities centered around 3D bioprinting technologies.

BioAssemblyBot® 200, or BAB200 as we call her, is an all-in-one platform that takes you from the idea stage quickly to execution.

3D structures made of collagen using mold design and fabrication

The Integrated biofabrication platform that is TSIM® and the BioAssemblyBot® 400 enables the intuitive fabrication of microfluidic systems.